BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

China

EW Group Partners with China's Sinopharm, the Largest Healthcare Provider.

EW Group represented by Chairman, Prof. Dato' Sri Dr Mike Chan, and HK VJM Ltd was represented by Mr Guo Liang, while NCL Solutions Sdn Bhd repre...

June 15, 2023 | News

MindRank Announces First-in-Human Phase 1 Study of MDR-001 in China

"The initiation of our FIH clinical trial with MDR-001 is an important milestone for MindRank which is yet another great validation of the potential of our...

June 15, 2023 | News

C2 PHARMA Receives Approval for Digoxin China DMF, Becoming China’s Only European Supplier of This API

C2 Pharma the global leader in manufacturing and supplying ophthalmic and niche active pharmaceutical ingredients (APIs), proudly announces the appro...

June 14, 2023 | News

Zhongchao Inc. Launches Digital Education Platform for Common Disease Diagnosis and Treatment

This Platform is designed to elevate the clinical decision-making acumen and patient service capabilities of healthcare professionals, thereby delivering o...

June 13, 2023 | News

Eccogene Raises CNY 180M in Series B Financing for Metabolic Disease Treatments

Eccogene Inc., a clinical-stage biotechnology company developing innovative therapeutic solutions for metabolic diseases, announced a CNY 1...

June 12, 2023 | News

China Approves World's First Vaccine for XBB Descendent Lineages of SARS-CoV-2

WestVac Biopharma and its subsidiary company WestVac Biopharma (Guangzhou) leveraged the rapid response of the insect cell expression platform on construct...

June 12, 2023 | News

Dizal Highlights Oncology Pipeline Strength at 2023 ASCO, Leading China's Biotech Innovation

Two highly anticipated oral presentations captured attention: first pivotal study of sunvozertinib (WU-KONG6) and multinational pivotal study of golidoci...

June 08, 2023 | News

EVERSANA Allies with China Resource Pharmaceutical for Global Novel Treatments

Together, the two organizations will collaborate on helping expand access to innovative healthcare solutions that are available both in and outside of ...

June 02, 2023 | News

WuXi Biologics to Increase Manufacturing Capacity in Germany

- The investment promotes the creation of additional high-skilled jobs - As part of WuXi Biologics' global manufacturing network, a new drug p...

June 02, 2023 | News

Innovent Collaborates with Merck KGaA to Study Combination Therapy for KRASG12C-mutated NSCLC in China

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...

June 02, 2023 | News

Vazyme Signs Global Strategic Cooperation Agreement with Azenta

Dr. Nie Junwei, General Manager of Life Science Division, Vazyme, and Mr. George Ge, General Manager of Azenta China, witnessed by Dr. Cao Lin, C...

June 01, 2023 | News

Merck Study: mRNA Technology a ‘Game Changer’ for Asia-Pacific Vaccine Manufacturers

87% of respondents deemed mRNA a key modality for the future More than 60% of vaccine makers surveyed plan revamp or new facilities for mRNA m...

June 01, 2023 | News

Luzhu Biotechnology's LZ901 Completes Phase II Clinical Trial for Herpes Zoster Vaccine

Beijing Luzhu Biotechnology Co., Ltd. ("Luzhu Biotechnology" or the "Company", together with its subsidiaries, the "Group", stock code: 02480.HK), a l...

May 31, 2023 | News

Antengene's ATG-022 Receives Orphan Drug Designations for Gastric and Pancreatic Cancers

Orphan Drugs, also known as Rare Disease Drugs, refers to pharmaceutical products developed for the prevention, diagnosis, and treatment of rare diseases o...

May 24, 2023 | News

Stay Connected